
Sign up to save your podcasts
Or
With the recent approval and arrival of Zepbound in B.C this week - a powerful rival to Ozempic, and generics potentially right around the corner, it's part of a growing movement that's changing how we treat obesity as a chronic disease, and not a lifestyle failure.
Guest: Dr. Akshay Jain - Endocrinologist based in Surrey, B.C
Learn more about your ad choices. Visit megaphone.fm/adchoices
With the recent approval and arrival of Zepbound in B.C this week - a powerful rival to Ozempic, and generics potentially right around the corner, it's part of a growing movement that's changing how we treat obesity as a chronic disease, and not a lifestyle failure.
Guest: Dr. Akshay Jain - Endocrinologist based in Surrey, B.C
Learn more about your ad choices. Visit megaphone.fm/adchoices
197 Listeners
3 Listeners
75 Listeners
14 Listeners
8 Listeners
6 Listeners
55 Listeners
0 Listeners
47 Listeners
0 Listeners
7 Listeners
224 Listeners
82 Listeners
414 Listeners
98 Listeners
144 Listeners
0 Listeners
5 Listeners
1 Listeners
5 Listeners
10 Listeners
567 Listeners
119 Listeners
44 Listeners
0 Listeners
1 Listeners
35 Listeners
1 Listeners
55 Listeners
3 Listeners
69 Listeners